Williams Jones Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Williams Jones Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.5M	Buy	199,576 +56,340	+39%	+$7.03M	0.31%	59
2025 Q4	$17.5M	Buy	143,236 +132,190	+1,197%	+$15.2M	0.2%	70
2025 Q3	$1.11M	Sell	11,046 -2,330	-17%	-$210K	0.01%	240
2025 Q2	$1.11M	Sell	13,376 -43,579	-77%	-$3.48M	0.01%	245
2025 Q1	$4.62M	Sell	56,955 -24,515	-30%	-$2.19M	0.06%	135
2024 Q4	$7.34M	Sell	81,470 -59,017	-42%	-$5.72M	0.09%	119
2024 Q3	$13.9M	Buy	140,487 +14,225	+11%	+$1.4M	0.16%	91
2024 Q2	$11.7M	Buy	126,262 +879	+0.7%	+$78.8K	0.15%	98
2024 Q1	$11.9M	Buy	125,383 +6,780	+6%	+$629K	0.15%	95
2023 Q4	$10.6M	Sell	118,603 -30,350	-20%	-$2.25M	0.15%	98
2023 Q3	$10.9M	Sell	148,953 -11,572	-7%	-$924K	0.17%	91
2023 Q2	$13.4M	Sell	160,525 -351	-0.2%	-$29.4K	0.2%	82
2023 Q1	$12.3M	Buy	160,876 +72,408	+82%	+$6.01M	0.19%	91
2022 Q4	$7.34M	Sell	88,468 -6,129	-6%	-$496K	0.12%	119
2022 Q3	$7.5M	Buy	94,597 +6,042	+7%	+$509K	0.13%	110
2022 Q2	$6.58M	Sell	88,555 -8,225	-8%	-$617K	0.11%	128
2022 Q1	$8.7M	Sell	96,780 -12,998	-12%	-$1.2M	0.12%	111
2021 Q4	$12.3M	Sell	109,778 -2,246	-2%	-$271K	0.15%	92
2021 Q3	$14.1M	Sell	112,024 -3,327	-3%	-$428K	0.2%	83
2021 Q2	$15.6M	Buy	115,351 +12,149	+12%	+$1.6M	0.22%	81
2021 Q1	$14M	Buy	103,202 +8,022	+8%	+$1.2M	0.22%	79
2020 Q4	$13.4M	Buy	95,180 +1,595	+2%	+$204K	0.22%	78
2020 Q3	$10.4M	Buy	93,585 +6,098	+7%	+$684K	0.19%	80
2020 Q2	$9.79M	Buy	87,487 +19,440	+29%	+$1.91M	0.2%	79
2020 Q1	$5.27M	Sell	68,047 -5,532	-8%	-$490K	0.14%	94
2019 Q4	$7M	Sell	73,579 -6,280	-8%	-$543K	0.13%	98
2019 Q3	$6.09M	Buy	+79,859	New	+$6.64M	0.13%	102

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Williams Jones Wealth Management's XBI Position: Q1 2026 in Review

Williams Jones Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q1 2026, buying an estimated $7.03M and bringing the position to 199,576 shares worth $25.5M. The position accounts for 0.31% of the portfolio, ranked #59.

Williams Jones Wealth Management first reported a position in XBI in Q3 2019 and has held it in 27 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Williams Jones Wealth Management held 199,576 shares of State Street SPDR S&P Biotech ETF worth $25.5M as of Q1 2026.
Williams Jones Wealth Management bought 56,340 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $7.03M.
State Street SPDR S&P Biotech ETF made up 0.31% of Williams Jones Wealth Management's portfolio in Q1 2026, its #59 holding.
Williams Jones Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 27 quarters since.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Williams Jones Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.